Phase I/II study of CTLA-4 inhibitor AGEN1884 + PD-1 Inhibitor AGEN2034 in patients with advanced/refractory solid tumors, with expansion into 2L cervical cancer and solid tumors
Coward, J., Lemech, C., Meniawy, T., Dupont, C.D., Gonzalez, A.M., Lim, M., Savitsky, D., Carini, M., Hu, S., Shebanova, O., Dow, E., Ortuzar, W., Buell, J.S., Stein, R.B., Youssoufian, H.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Phase I/II, open-label, multiple ascending dose trial of AGEN2034, an anti–PD-1 monoclonal antibody, in advanced solid malignancies: Results of dose escalation in advanced cancer and expansion cohorts in subjects with relapsed/refractory cervical cancer
Drescher, C., Moore, K.N., Liu, J.F., O’Malley, D.M., Wang, E.W., Wang, J.S.-Z., Subbiah, V., Wilky, B.A., Yuan, G., Dupont, C.D., Gonzalez, A.M., Savitsky, D., Coulter, S., Shebanova, O., Dow, E., Ortuzar, W., Buell, J.S., Stein, R.B., Youssoufian, H.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1168PPhase I/II study of CTLA-4 inhibitor AGEN1884 + PD-1 Inhibitor AGEN2034 in patients with advanced/refractory solid tumors, with expansion into 2L cervical cancer and solid tumors
Coward, J, Lemech, C, Meniawy, T, Dupont, C D, Gonzalez, A M, Lim, M, Savitsky, D, Carini, M, Hu, S, Shebanova, O, Dow, E, Ortuzar, W, Buell, J S, Stein, R B, Youssoufian, H
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1158PPhase I/II, open-label, multiple ascending dose trial of AGEN2034, an anti-PD-1 monoclonal antibody, in advanced solid malignancies: Results of dose escalation in advanced cancer and expansion cohorts in subjects with relapsed/refractory cervical cancer
Drescher, C, Moore, K N, Liu, J F, O'Malley, D M, Wang, E W, Wang, J S-Z, Subbiah, V, Wilky, B A, Yuan, G, Dupont, C D, Gonzalez, A M, Savitsky, D, Coulter, S, Shebanova, O, Dow, E, Ortuzar, W, Buell, J S, Stein, R B, Youssoufian, H
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1167PPhase I, open-label ascending dose trial of anti-CTLA-4 monoclonal antibody AGEN1884 in advanced solid malignancies, with expansion to patients refractory to recent anti-PD-1/PD-L1 therapy
Wilky, B A, Kumthekar, P, Wesolowski, R, Hwang, J J, Park, S I, Yuan, G, Dupont, C D, Lim, M, Shebanova, O, Cuillerot, J-M, Dow, E, Ortuzar, W, Raizer, J J, Drouin, E, Wilson, N, Gonzalez, A M, Goldberg, J M, Buell, J S, Stein, R B, Youssoufian, H
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Randomized, open-label study of pemetrexed/carboplatin followed by maintenance pemetrexed versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with advanced non-small cell lung cancer (NSCLC) of nonsquamous histology
Zinner, R., Saxman, S., Peng, G., Ortuzar, W. F.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel
Rixe, Olivier, Ortuzar, Waldo, Alvarez, Manuel, Parker, Ricardo, Reed, Eddie, Paull, Ken, Fojo, Tito
Published in Biochemical pharmacology (24.12.1996)
Published in Biochemical pharmacology (24.12.1996)
Get full text
Journal Article
Brain metastases (BM) as the primary site of relapse in two randomized phase III pemetrexed (P) trials in advanced non-small cell lung cancer (NSCLC)
Ortuzar, W. F., Pennella, E. J., John, W. J., Simms, L., Peng, G., Treat, J., Obasaju, C. K.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Identification of non-cross-resistant platinum compounds with novel cytotoxicity profiles using the NCI anticancer drug screen and clustered image map visualizations
Fojo, Tito, Farrell, Nick, Ortuzar, Waldo, Tanimura, Hideyuki, Weinstein, John, Myers, Timothy G.
Published in Critical reviews in oncology/hematology (2005)
Published in Critical reviews in oncology/hematology (2005)
Get full text
Journal Article
Conference Proceeding
LBA O-9 Botensilimab, a novel innate/adaptive immune activator, plus balstilimab (anti-PD-1) for metastatic heavily pretreated microsatellite stable colorectal cancer
Bullock, A., Grossman, J., Fakih, M., Lenz, H., Gordon, M., Margolin, K., Wilky, B., Mahadevan, D., Trent, J., Bockorny, B., Moser, J., Balmanoukian, A., Schlechter, B., Ortuzar Feliu, W., Rosenthal, K., Bullock, B., Stebbing, J., Godwin, J., O'Day, S., Tsimberidou, A., El-Khoueiry, A.
Published in Annals of oncology (01.06.2022)
Published in Annals of oncology (01.06.2022)
Get full text
Journal Article